Literature DB >> 12395100

Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors.

Miriam Kolko1, Elena B de Turco, Nils Henrik Diemer, Nicolas G Bazan.   

Abstract

To define the significance of glutamate ionotropic receptors in sPLA -mediated neuronal cell death we used the NMDA receptor antagonist MK-801 and the AMPA receptor antagonist PNQX. In primary neuronal cell cultures both MK-801 and PNQX inhibited sPLA - and glutamate-induced neuronal death. [ H]Arachidonic acid release induced by both sPLA and glutamate was partially blocked by MK-801, indicating that the glutamate-NMDA-cPLA pathway contributes to sPLA -induced arachidonic acid release. Systemic administration of MK-801 to rats that had sPLA injected into the right striatum significantly decreased neuronal cell death. We conclude that glutamatergic synaptic activity modulates sPLA -induced neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395100     DOI: 10.1097/00001756-200210280-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.

Authors:  Michael D Jensen; Wenwen Sheng; Agnes Simonyi; Gary S Johnson; Albert Y Sun; Grace Y Sun
Journal:  Neurochem Int       Date:  2009-04-16       Impact factor: 3.921

2.  Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats.

Authors:  Germán Torregrosa; Fernando J Pérez-Asensio; María C Burguete; María Castelló-Ruiz; Juan B Salom; Enrique Alborch
Journal:  Exp Brain Res       Date:  2007-01       Impact factor: 1.972

Review 3.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

Review 4.  Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists.

Authors:  Grace Y Sun; Jianfeng Xu; Michael D Jensen; Sue Yu; W Gibson Wood; Fernando A González; Agnes Simonyi; Albert Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 5.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 6.  Lipoxygenase: an emerging target for stroke therapy.

Authors:  Klaus van Leyen
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

7.  Neuroprotective effects of a nanocrystal formulation of sPLA(2) inhibitor PX-18 in cerebral ischemia/reperfusion in gerbils.

Authors:  Qun Wang; Albert Y Sun; Jana Pardeike; Rainer H Müller; Agnes Simonyi; Grace Y Sun
Journal:  Brain Res       Date:  2009-06-13       Impact factor: 3.252

8.  Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients.

Authors:  H-W Kim; S I Rapoport; J S Rao
Journal:  Mol Psychiatry       Date:  2009-12-29       Impact factor: 15.992

9.  Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.

Authors:  Guna S D Moses; Michael D Jensen; Lih-Fen Lue; Douglas G Walker; Albert Y Sun; Agnes Simonyi; Grace Y Sun
Journal:  J Neuroinflammation       Date:  2006-10-07       Impact factor: 8.322

10.  Phospholipase A2 Inhibitor-Loaded Phospholipid Micelles Abolish Neuropathic Pain.

Authors:  Sonia Kartha; Lesan Yan; Meagan E Ita; Ahmad Amirshaghaghi; Lijun Luo; Yulong Wei; Andrew Tsourkas; Beth A Winkelstein; Zhiliang Cheng
Journal:  ACS Nano       Date:  2020-06-04       Impact factor: 15.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.